Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Fingolimod Hydrochloride Capsules

Approval Number

H20191019

CompanyNovartis Pharma Schweiz AG

Registration Date

August 20, 2019

Previous Approval Numbers

H20190044

Drug Information

Generic Name

盐酸芬戈莫德胶囊

Trade Name

捷灵亚

Dosage Form

胶囊剂

Strength

0.5mg(按C19H33NO2计)

Drug Type

化学药品

Registration Date

August 20, 2019

Expiry Date

July 11, 2024

Company Information

Applicant Company

Company NameNovartis Pharma Schweiz AG

Company Address

6343 Risch,Switzerland

Manufacturing Company

Company NameNovartis Pharma Stein AG

Company Address

Schaffhauserstrasse 4332 Stein,Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸芬戈莫德胶囊 - NMPA 批准文号 | MedPath